This course is designed to help understand pharmacovigilance quality management systems (QMS) and risk-based audits.
Since the introduction of the new pharmacovigilance legislation in the EU, QMS and self-audits have become an increasingly important topic. Companies have been challenged by regulators to implement risk-based audits where continual improvement of processes, systems and compliance to regulations needs to be demonstrated. This is required from the top of the company organisation in all areas of regulatory activity including clinical, pharmacovigilance, sales and marketing, IT and medical services.
This must-attend course will explain principles, approaches and regulatory expectations for the pharmacovigilance QMS and risk-based audits and has been designed to help in both the assessments of risk and the whole CAPA process. The highly participative programme will include a mix of presentations from our expert trainer, reallife case studies and practical workshop sessions which will help consolidate learning.
Benefits of attending:
QA representatives, EU QPPVs and all working in pharmacovigilance, regulatory, clinical and administrators responsible for the management of the CAPA systems.
You will be asked to design the QMS for a safety department that has recently been audited. You will need to devise a plan based on any risk elements and audit findings identified and look at designing a QMS approach with KPIs.
You will be presented with a series of findings from a regulatory inspection. You will have to look at the findings and work out priorities, devise root cause analyses and provide detailed CAPA plans which will include QMS activities.
Graeme Ladds (More...)
Graeme Ladds, Director of PharSafer, has over 30 years’ experience working in the pharmaceutical industry. Having started his career at Ashbourne Pharmaceuticals in 1989 as Head of Drug Safety & Medical Information, he went on to become Head of Global Pharmacovigilance at Shire Pharmaceuticals. He then set up his consultancy and specialist CRO company, PharSafer Associates Ltd, where he has been involved in establishing pharmacovigilance in companies, performing audits across Europe and the USA, SOP writing, acting as QP for companies, and helping with regulatory inspections.
NEW higher discounts for booking multiple places - bring your colleagues to make your training budget go further:
30% off the 2nd delegate; 40% off the 3rd delegate; 50% off the 4th delegate
Choose your date below - or reserve your place with no obligation for 7 days at ipi.academy: Reserve now | |||
16-17 Nov 2022 Live webinar 09:00-16:15 UK (London) |
|||
16-17 Nov 2022 Live webinar 09:00-16:15 UK (London) |
GBP 1,299 1,099 EUR 1,859 1,579 USD 2,098 1,786 Until 12 Oct* |
Enrol now
to attend Live webinar |
|
23-26 Jan 2023 Live webinar 13:30-17:00 UK (London) |
|||
23-26 Jan 2023 Live webinar 13:30-17:00 UK (London) |
GBP 1,299 1,099 EUR 1,869 1,589 USD 2,129 1,817 Until 19 Dec* |
Enrol now
to attend Live webinar |
|
22-23 May 2023 Live webinar 09:00-16:15 UK (London) |
|||
22-23 May 2023 Live webinar 09:00-16:15 UK (London) |
GBP 1,299 1,099 EUR 1,869 1,589 USD 2,129 1,817 Until 17 Apr 23* |
Enrol now
to attend Live webinar |
|
28-29 Sep 2023 Live webinar |
|||
28-29 Sep 2023 Live webinar |
GBP 1,299 1,099 EUR 1,869 1,589 USD 2,129 1,817 Until 24 Aug 23* |
Enrol now
to attend Live webinar |
|
Learn more about our face-to-face and webinar training formats.
* Note the early booking discount cannot be combined with any other offers or promotional code. As such, discounts for the 2nd/3rd/4th attendees are based on the full price of the course. Please contact us for pricing if you wish to send more than 4 delegates.